Skip to main content

Table 2 Clinical and hematological parameter distribution of the study subjects, at JUSH from July-September 2012

From: Prevalence of cytopenias in both HAART and HAART naïve HIV infected adult patients in Ethiopia: a cross sectional study

Variables Female Male HAART patients HAART naïve Total
Min-Max Mean ± SD Min-Max Mean ± SD Min-Max Mean ± SD Min-Max Mean ± SD Min-Max Mean ± SD
Age 16-70 32.1 ± 9.38 17-68 38.4 ± 10.04 20-67 36.9 ± 9.5 16-70 33.5 ± 10.3 16-70 34.7 ± 10
HIV dur. (months) 1-117 31 ± 27.6 1-96 29 ± 24.3 1-117 50.6 ± 25.7 1-90 18.9 ± 18.7 1-117 30 ± 26.3
ART dur. (months) 1-96 41 ± 25.8 1-76 36 ± 21.9 1-96 39 ± 24.5 1-96 39.11 ± 24.46
CD4 count 5-1377 406 ± 232.6 36-1421 343 ± 199.07 5-1314 429.2 ± 337.5 7.6-16.9 352 ± 207 5-1421 380 ± 221
Hemoglobin 4.3-15.6 11.9 ± 1.65 7.8-18.6 12.6 ± 2.1 4.3-18.6 12.6 ± 1.85 2.4-13 11.9 ± 1.8 4.3-18.6 12.2 ± 1.9
WBC × 103 1.8-13.0 6.007 ± 1.92 2.3-11.6 6.069 ± 1.78 1.8-12.5 6.28 ± 2 1.2-9.88 5.89 ± 1.76 1.8-13 6.03 ± 1.86
ANC × 103 1.062-9.88 3.549 ± 1.56 .920-8.424 3.530 ± 1.39 0.92-9.5 3.76 ± 1.7 0.35-5.05 3.42 ± 1.3 0.92-9.88 3.54 ± 1.48
TLC × 103 0.349-5.05 1.854 ± 0.76 .543-4.325 1.854 ± 0.706 0.57-4.3 1.9 ± 0.7 13-987 1.82 ± 0.75 0.349-5.05 1.85 ± 0.74
Platelet count × 103 62.0-987.0 296.769 ± 135.22 13-890 276.953 ± 149.89 73-750 290.3 ± 111.5 21-1421 287.6 ± 156.2 13-987 288.59 ± 141.59